Tattoo pigments as a foreign factor and the immune response

Tattoos are no longer rare: according to the data cited by the review authors, approximately 11.7–31.5% of the population has at least one tattoo, with peak prevalence in the 25–34 age group [1]. Against this background, it is important to consider not only local skin reactions but also broader immune consequences of tattooing. Pigments are deposited into the dermis, and the skin is an immunologically active organ that not only retains foreign material but also continuously interacts with it via innate and adaptive immune cells. Therefore, tattoo pigment should not be viewed as a neutral dye: it is a foreign substance capable of sustaining chronic antigenic stimulation.

This helps explain why a tattoo-related response does not always remain confined to the tattooed area. In a typical scenario, the immune response stays local: pigment particles are taken up by macrophages and, via lymphatic pathways, reach regional lymph nodes, where they can accumulate and cause reactive changes [4]. This is how localized lymphadenopathy develops.

Lymphadenopathy refers to changes in the size and/or consistency of lymph nodes; in clinical practice, it is commonly divided into localized (one anatomic region involved) and generalized (multiple noncontiguous nodal regions involved) forms [2]. For clinicians, lymphadenopathy is always a diagnostic signal because it may reflect infection, malignancy, or an autoimmune or granulomatous process. In this setting, tattoos are often omitted from the differential diagnosis, even though they may represent a source of chronic antigenic burden.

Review design and analytic approach

The review by Jacobi et al. focused on this under-recognized association. The aim was to systematize data on localized and generalized lymphadenopathies associated with tattoos, including cases of sarcoidosis. The authors searched PubMed on November 25, 2025, using the query «tattoo AND lymphadenopathy». In total, 44 publications were identified; after screening, 33 were included in qualitative synthesis. For each publication, they analyzed patient age and medical history, tattoo characteristics, clinical presentation, lymphadenopathy localization, diagnostic workup and histology findings, treatment, and outcomes.

Cases were included when an association with tattooing was supported either by pigment identified in a lymph node or by non-caseating granulomas in skin/lymph nodes with a confirmed sarcoidosis diagnosis. Isolated cutaneous reactions without lymph node involvement, tattoo-associated uveitis without lymphadenopathy, and publications without sufficient clinicopathologic detail were excluded from analysis [1].

Localized and systemic scenarios

The results described two distinct clinical scenarios.

The first was localized lymphadenopathy. It was reported in 15 of 33 publications, involving 16 patients. The most commonly involved lymph nodes were axillary, cervical, and inguinal—i.e., the groups draining the tattooed area. In most cases, involvement was unilateral and anatomically matched the tattoo site.

Histopathology was fairly uniform: pigment-laden macrophages, dilated sinuses, and reactive hyperplasia, with no evidence of malignancy or granuloma formation. This is an important observation because it supports a mechanism of passive lymphatic transport of pigment rather than necessarily systemic immune dysregulation [4].

The second scenario was generalized lymphadenopathy, often associated with sarcoidosis. These cases appeared in 18 of 33 publications; sarcoidosis was confirmed in 13 patients—histologically in 12, and in one based on the clinical presentation of Lofgren syndrome (an acute form of sarcoidosis that typically presents with the combination of enlarged intrathoracic lymph nodes, erythema nodosum, arthralgias, and fever). The lymph nodes most often involved were intrathoracic, primarily hilar (located at the “hilum” of the lungs—where the bronchi, vessels, and nerves enter the lung) and mediastinal (located in the mediastinum, the deep central space of the chest between the right and left lungs—around the heart, esophagus, and trachea) [3].

Unlike localized cases, this distribution cannot be explained solely by drainage from a specific tattoo site and points to a more complex immune scenario. In some patients, the process was accompanied by systemic manifestations: exertional dyspnea, cough, erythema nodosum, arthralgias, fever, and, in some cases, ophthalmologic symptoms. The authors interpret this as a situation in which tattoo pigment may act not merely as a passive material but as a biologically relevant cofactor or trigger in the context of systemic immune dysregulation characteristic of sarcoidosis [3].

Diagnostic pitfalls and clinical significance

The diagnostic side of the problem deserves special attention. In many reported cases, affected lymph nodes were FDG-avid on PET-CT (i.e., they showed increased uptake of the radioactive glucose analog fluorodeoxyglucose). This is typical of tissues with high metabolic activity, including tumors and inflammatory foci, and therefore was initially interpreted as suspicious for malignancy. As a result, patients often underwent invasive procedures—fine-needle aspiration, biopsy, and sometimes lymphadenectomy.

One of the main practical takeaways of the article is that tattoo history—including old tattoos, cosmetic tattooing, and prior laser removal—should be part of the workup for unexplained lymphadenopathy. Otherwise, a benign pigment-associated reaction or a sarcoid-like process may be misclassified as metastatic disease or lymphoma [2].

It is also notable that disease onset could follow immune-modulating events. The authors describe cases in which lymphadenopathy appeared after laser tattoo removal, during immune checkpoint inhibitor therapy, or after SARS-CoV-2 vaccination. This does not establish direct causality in every case, but it suggests that shifts in immune balance can make a previously silent or subtle process clinically apparent.

As for which pigments are more likely to cause such reactions, the review does not provide a clear answer. In the introduction, the authors note that tattoo inks may contain organic pigments and heavy metals. However, their analysis indicates that the role of specific ink components or particular colors has not been defined and remains an open question.

The limitations of the review also matter. It is based largely on clinical cases and small series, so it is not an incidence estimate but a structured synthesis of reported scenarios. In addition, publications varied in completeness of reporting, follow-up duration, and treatment details.

Conclusion

For clinicians, this study provides clear practical cues for assessment. A local reaction to tattoo pigment may present with an enlarged regional lymph node without granulomas or loss of nodal architecture. In contrast, generalized lymphadenopathy—especially with hilar and mediastinal involvement—requires exclusion of a broader granulomatous process, including sarcoidosis.

Careful history-taking about tattoos, permanent makeup, and pigment removal procedures can help prevent unnecessary invasive interventions and diagnostic errors.

Overall, the review shows that tattoo pigment is not only a cosmetic trace in the skin, but also a potential immunologic trigger. In most cases, the response remains local and is linked to lymphatic drainage of pigment into regional lymph nodes. However, in some cases, the process extends beyond the skin and takes on systemic features, including sarcoidosis-like presentations. This is why the history of tattoos should be a routine part of evaluating unexplained lymphadenopathy.

References

1. Jacobi M.M., Bereswill S., Heimesaat M.M. Tattoos causing local and even generalized lymphadenopathies, including sarcoidosis. Eur J Microbiol Immunol (Bp) 2026; 16(1): 59–66. DOI: 10.1556/1886.2026.00009.
2. Gaddey H.L., Riegel A.M. Unexplained lymphadenopathy: evaluation and differential diagnosis. Am Fam Physician 2016; 94(11): 896–903.
3. Grunewald J., Grutters J.C., Arkema E.V. et al. Sarcoidosis. Nat Rev Dis Primers 2019; 5(1): 45.
4. Baranska A., Shawket A., Jouve M. et al. Unveiling skin macrophage dynamics explains both tattoo persistence and strenuous removal. J Exp Med 2018; 15(4): 115–1133.